sodium salicylate has been researched along with rotenone in 3 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (rotenone) | Trials (rotenone) | Recent Studies (post-2010) (rotenone) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 4,407 | 6 | 1,648 |
Protein | Taxonomy | sodium salicylate (IC50) | rotenone (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8 | |
NADH-ubiquinone oxidoreductase chain 1 | Bos taurus (cattle) | 0.015 | |
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | Bos taurus (cattle) | 0.0051 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 3.6486 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.87 | |
Acyl carrier protein, mitochondrial | Bos taurus (cattle) | 0.0051 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nehru, B; Thakur, P | 2 |
Karuppagounder, SS; Madathil, SK; Mohanakumar, KP | 1 |
3 other study(ies) available for sodium salicylate and rotenone
Article | Year |
---|---|
Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Catalase; Cytokines; Dopamine; Homovanillic Acid; Inflammation; Male; Monoamine Oxidase; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rotenone; Sodium Salicylate | 2013 |
Sodium salicylate protects against rotenone-induced parkinsonism in rats.
Topics: Amphetamine; Animals; Apomorphine; Corpus Striatum; Cyclooxygenase Inhibitors; Dopamine; Dose-Response Relationship, Drug; Electron Transport Complex I; Glutathione; Hydroxyl Radical; Male; Neurons; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Sodium Salicylate; Substantia Nigra; Superoxide Dismutase; Uncoupling Agents | 2013 |
Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.
Topics: alpha-Synuclein; Animals; Body Weight; Glutathione; HSP70 Heat-Shock Proteins; Male; Nerve Tissue Proteins; Oxidation-Reduction; Parkinson Disease; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Rotenone; Sodium Salicylate; Ubiquitin | 2014 |